Quintiles Transnational Holdings Inc. Company Profile
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
News Articles
[Quintiles Transnational] nets $496mm through IPO
CRO [Quintiles Transnational Holdings Inc.] has netted $496mm through its initial public offering of 13mm common shares at $40. Existing shareholders also sold 10.6mm shares and will cover an overallo...
Quintiles files for IPO of up to $600 mln
Feb 15 (Reuters) - Quintiles Transnational Holdings Inc, the largest provider of testing services to drugmakers, filed with U.S. regulators on Friday to raise up to $600 million in an initial public o...
TEXT-S&P rates Quintiles Transnational loan 'BB-'
Oct 10 - Overview -- Research Triangle Park, N.C.-based contract services provider Quintiles Transnational Corp. is issuing $175 million in incremental term debt to fund a shareholder distribut...
UPDATE 1-Quintiles files for IPO of up to $600 mln
Feb 15 (Reuters) - Quintiles Transnational Holdings Inc, the largest provider of testing services to drugmakers, filed with U.S. regulators on Friday to raise up to $600 million in an initial public o...
Quintiles prices upsized IPO at high end of range
May 8 (Reuters) - Drug researcher Quintiles Transnational Holdings raised $947.4 million in its initial public offering on Wednesday night by pricing 20 percent more shares than expected at the high e...
IPO or ATM? Quintiles insiders take cash, Receptos enters market
The world's largest contract research organization Quintiles Transnational Holdings raised $489.8 million in net proceeds from one of the largest life science initial public offerings this year and i...
Testing services provider Quintiles sets IPO range at $36-$40/shr
April 26 (Reuters) - Quintiles Transnational Holdings Inc, the largest provider of testing services to drugmakers, said it expects a price range of between $36 and $40 per share for its initial public...
Quintiles shares rise 10 pct in market debut
May 9 (Reuters) - Shares of drug research company Quintiles Transnational Holdings rose as much as 10 percent in its market debut, valuing the company at about $5.70 billion.
Drugs and Medications
Bbcream [E-House Korea Holdings International]
Warm sap patch [E-House Korea Holdings International]
Warm sap patch [E-House Korea Holdings International]
PubMed Articles
The Neurobiology of Erythropoietin.
Genetic Counseling: A Transnational Perspective.
Although the basic goal and components of genetic counseling appears to be the same across the globe, judged by my experiences there are significant differences in the provision of genetic counseling...
Abstract AIMS: The study was conducted to identify movement patterns of disease conveyors in the New Zealand pig industry. The principal objective of the study was to identify data relating to the fre...
Objectives. We sought to investigate, across different socioeconomic groups, the proportion of household medicine expenses that were paid by households and the proportion paid by the Brazilian nationa...
Clinical Trials
The purpose of this study is to explore the safety and tolerability of AZD5069 at steady-state, following twice a day oral dosing in healthy subjects. AZD5069 is being developed by AstraZ...
Experimental Vaccine for Plasmodium Falciparum Malaria
This study will evaluate the safety of two experimental malaria vaccines in healthy volunteers and examine their immune response to them. Safety will be assessed by comparing vaccine side...
Companies
Quintiles Transnational Holdings Inc.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more...
Quintiles Transnational Holdings, Inc.
Quintiles Transnational Corporation
Quintiles Transnational is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare. Founded in 1982 and headquartered near...
Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare...
Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare...
More Information about "Quintiles Transnational Holdings Inc." on BioPortfolio
We have published hundreds of Quintiles Transnational Holdings Inc. news stories on BioPortfolio along with dozens of Quintiles Transnational Holdings Inc. Clinical Trials and PubMed Articles about Quintiles Transnational Holdings Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quintiles Transnational Holdings Inc. Companies in our database. You can also find out about relevant Quintiles Transnational Holdings Inc. Drugs and Medications on this site too.
